InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Friday, 09/11/2020 2:57:11 PM

Friday, September 11, 2020 2:57:11 PM

Post# of 425847
Amarin at least gets royalties with TEVA agreement...

in which event Teva would pay Amarin royalties on its generic version of Vascepa



https://basic.10jqka.com.cn/ajax/usaph/pubDetail/85fcf343632541c9_html

Very good chance this means API agreement....

Hik & Red will not be able to compete with TEVA.

Hik must launch by November 17th to maintain 180 day window.

I wonder if TEVA would be interested in other indications in US?

Go TEVA!!!

BB

If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News